AI assistant
Sending…
Sopharma AD — M&A Activity 2023
Nov 7, 2023
2543_rns_2023-11-07_3fc12ba1-6c60-4e5c-a315-0549a88affba.pdf
M&A Activity
Open in viewerOpens in your device viewer
Current report №196/2023 Dated November 7, 2023
NOTIFICATION
"Sopharma" AD (the Company) notifies that the Serbian Commission for Protection of Competition has authorized Sopharma AD to acquire the manufacturer Pharmanova in stages. The deal will take place in several stages, starting with the acquisition of 25% of the company's capital.
Ognian Donev
More from Sopharma AD
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Transaction in Own Shares
2026
May 19
Transaction in Own Shares
2026
May 18
Transaction in Own Shares
2026
May 15
Transaction in Own Shares
2026
May 14